PSP Research »

Belite Bio shares owned by PSP Research

Quarter-by-quarter ownership of Belite Bio (BLTE) shares owned by PSP Research from 13F filings

Historical chart of PSP Research investment in Belite Bio

Tip: Access up to 7 years of quarterly data

All positions including Belite Bio held by PSP Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Belite Bio by PSP Research

Quarter filed Position value Share count Share price at filing
2025-12-31 $551k 3.4k 159.96

More positions owned by PSP Research

Ishares Tr 0-3 Mnth Treasry (SGOV)
Praxis Precision Medicines I Com New (PRAX)
Travere Therapeutics (TVTX)
Tyra Biosciences (TYRA)
Pharvaris N V (PHVS)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Celldex Therapeutics Com New (CLDX)
Cg Oncology (CGON)
Belite Bio Sponsored Ads (BLTE)
Ascendis Pharma A/s Sponsored Adr (ASND)
Apellis Pharmaceuticals (APLS)
Terns Pharmaceuticals (TERN)
Revolution Medicines (RVMD)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Bridgebio Pharma (BBIO)

View all positions for PSP Research

Top funds holding Belite Bio

RA Capital Management
Rtw Investments
Vestal Point Capital
Soleus Capital Management
Eventide Asset Management
Marshall Wace
UBS Group
Perceptive Advisors
Goldman Sachs Group
ADAR1 Capital Management
Millennium Management
State Street Corporation
Citadel Advisors
Geode Capital Management
Jpmorgan Chase & Co

View all funds holding Belite Bio